Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 11 de 11
Filtrar
Mais filtros

Medicinas Complementares
Base de dados
País/Região como assunto
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Zhonghua Yu Fang Yi Xue Za Zhi ; 57(6): 849-856, 2023 Jun 06.
Artigo em Chinês | MEDLINE | ID: mdl-37357203

RESUMO

Objective: To identify the main metals involved in cognitive impairment in the Chinese oldest old, and explore the association between these metal exposures and cognitive impairment. Methods: A cross-sectional study was conducted on 1 568 participants aged 80 years and older from Healthy Aging and Biomarkers Cohort Study (2017 to 2018). Fasting venous blood was collected to measure the levels of nine metals (selenium, lead, cadmium, arsenic, antimony, chromium, manganese, mercury, and nickel). The cognitive function of these participants was evaluated by using the Chinese version of the Mini-Mental State Examination (CMMSE). The random forest (RF) was applied to independently identify the main metals that affected cognitive impairment. The multivariate logistic regression model and restricted cubic splines (RCS) model were used to further verify the association of the main metals with cognitive impairment. Results: The age of 1 568 study subjects was (91.8±7.6) years old, including 912 females (58.2%) and 465 individuals (29.7%) with cognitive function impairment. Based on the RF model (the out-of-bag error rate was 22.9%), the importance ranking of variables was conducted and the feature screening of five times ten-fold cross-validation was carried out. It was found that selenium was the metal that affected cognitive function impairment, and the other eight metals were not included in the model. After adjusting for covariates, the multivariate logistic regression model showed that with every increase of 10 µg/L of blood selenium levels, the risk of cognitive impairment decreased (OR=0.921, 95%CI: 0.889-0.954). Compared with the lowest quartile(Q1) of blood selenium, the ORs (95%CI) of Q3 and Q4 blood selenium were 0.452 (0.304-0.669) and 0.419 (0.281-0.622) respectively. The RCS showed a linear dose-response relationship between blood selenium and cognitive impairment (Pnonlinear>0.05). Conclusion: Blood selenium is negatively associated with cognitive impairment in the Chinese oldest old.


Assuntos
Disfunção Cognitiva , Selênio , Idoso de 80 Anos ou mais , Feminino , Humanos , Estudos de Coortes , Estudos Transversais , Metais/análise , Disfunção Cognitiva/epidemiologia , China/epidemiologia
2.
Zhonghua Liu Xing Bing Xue Za Zhi ; 43(2): 195-200, 2022 Feb 10.
Artigo em Chinês | MEDLINE | ID: mdl-35184484

RESUMO

Objective: To investigate the association of blood lead and blood selenium with serum high-sensitivity C-reactive protein (hs-CRP) among Chinese adults aged 19 to 79 years. Methods: The participants were enrolled from the first wave of China National Human Biomonitoring (CNHBM) conducted from 2017 to 2018. 10 153 participants aged 19 to 79 years were included in this study. Fasting blood samples were obtained from participants. Lead and selenium in whole blood and hs-CRP in serum were measured. Individuals with hs-CRP levels above 3.0 mg/L were defined as elevated hs-CRP. Generalized linear mixed models and restricted cubic spline models were used to analyze the association of blood lead and blood selenium with elevated hs-CRP. Logistic regression models were used to analyze the multiplicative scale and additive scale interaction between blood lead and blood selenium on elevated hs-CRP. Results: The age of participants was (48.91±15.38) years, of which 5 054 (61.47%) were male. 1 181 (11.29%) participants were defined as elevated hs-CRP. After multivariable adjustment, results from generalized linear models showed that compared with participants with the lowest quartile of blood lead, the OR (95%CI) of elevated hs-CRP for participants with the second, third, and highest quartiles were 1.14 (0.94-1.37), 1.25 (1.04-1.52) and 1.38 (1.13-1.68), respectively. When compared with participants with the lowest quartile of blood selenium, the OR (95%CI) of elevated hs-CRP for participants with the second, third and highest quartiles were 0.86 (0.72-1.04), 0.91 (0.76-1.11), and 0.75 (0.61-0.92), respectively. Results from the interaction analysis showed no significant interaction between lead and selenium on elevated hs-CRP. Conclusion: Blood concentration of lead was positively associated with elevated serum hs-CRP, and blood concentration of selenium was inversely related to elevated hs-CRP, while blood lead and selenium did not present interaction on elevated hs-CRP.


Assuntos
Proteína C-Reativa , Selênio , Adulto , Idoso , Povo Asiático , Biomarcadores , Proteína C-Reativa/análise , China/epidemiologia , Humanos , Masculino , Pessoa de Meia-Idade , Fatores de Risco , Adulto Jovem
3.
Eur Rev Med Pharmacol Sci ; 22(11): 3402-3407, 2018 06.
Artigo em Inglês | MEDLINE | ID: mdl-29917191

RESUMO

OBJECTIVE: Gastric cancer is the most common gastrointestinal malignancy and the leading cause of cancer-related deaths in East Asia. Increasing evidence has revealed that autophagy is closely associated with tumor initiation and progression. The present work aimed to investigate the role of autophagy in adjuvant chemotherapy for gastric cancer. MATERIALS AND METHODS: Gastric cancer stem cells (CSCs) were isolated from gastric cancer cell lines using the cell surface markers CD44 and CD54 and cultured in a three-dimensional cell culture system. Western blotting was used to detect their protein expression levels in gastric CSCs. In addition, the cells were treated with inhibitors to investigate the underlying mechanisms of autophagy. RESULTS: After isolation of gastric CSCs expressing CD44 and CD54, Western blot analysis showed that the levels of the autophagic marker LC3II were markedly enhanced in CD44+CD54+ gastric CSCs. Moreover, the ratio of LC3II/LC3I protein levels was higher in CD44+CD54+ gastric CSCs than in non-CSCs. By contrast, both a chemotherapeutic agent (5-fluorouracil) and autophagy inhibitor (chloroquine) exhibited an inhibitory effect on the cell viability of gastric CSCs, and their combination further enhanced such inhibitory effects. Mechanistically, the addition of Notch inhibitor decreased the cell viability of gastric CSCs treated with 5-fluorouracil and chloroquine. In addition, 5-fluorouracil and chloroquine both increased the expression of Notch1 in gastric CSCs. CONCLUSIONS: These findings show that autophagy regulated drug sensitivity of gastric cancer cells through the Notch signaling pathway.


Assuntos
Autofagia , Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos , Proteínas Associadas aos Microtúbulos/biossíntese , Células-Tronco Neoplásicas/metabolismo , Receptor Notch1/metabolismo , Transdução de Sinais/efeitos dos fármacos , Neoplasias Gástricas/tratamento farmacológico , Neoplasias Gástricas/patologia , Linhagem Celular Tumoral , Sobrevivência Celular/efeitos dos fármacos , Cloroquina/farmacologia , Sinergismo Farmacológico , Fluoruracila/farmacologia , Humanos , Receptores de Hialuronatos/biossíntese , Molécula 1 de Adesão Intercelular/biossíntese , Receptor Notch1/antagonistas & inibidores , Neoplasias Gástricas/metabolismo
4.
Eur J Surg Suppl ; (574): 51-3, 1994.
Artigo em Inglês | MEDLINE | ID: mdl-7531021

RESUMO

Fifty cases of primary liver cancer were treated by electrochemical therapy (ECT). Tumour size ranged from 3.5 to 21.0 cm. ECT was performed by administration of 6-10 V, 50-100 mA and an electric quantity of 300-1000 C. Duration of treatment was one and a half to four hours. There was an inverse relationship between tumour size and curative effect. There was no death within three months of treatment. Six- and 12-month survival was 88% and 69%, respectively. In conclusion, ECT is an effective treatment which prolongs the patients' life. We have found the method to be of practical value in the management of liver cancers in the intermediate or advanced stage.


Assuntos
Terapia por Estimulação Elétrica/métodos , Neoplasias Hepáticas/terapia , Adulto , Idoso , Terapia por Estimulação Elétrica/efeitos adversos , Eletroquímica , Feminino , Seguimentos , Humanos , Neoplasias Hepáticas/sangue , Neoplasias Hepáticas/diagnóstico por imagem , Neoplasias Hepáticas/mortalidade , Neoplasias Hepáticas/patologia , Masculino , Pessoa de Meia-Idade , Indução de Remissão , Taxa de Sobrevida , Fatores de Tempo , Resultado do Tratamento , Ultrassonografia , alfa-Fetoproteínas/metabolismo
7.
Zhong Xi Yi Jie He Za Zhi ; 9(3): 137-40, 131, 1989 Mar.
Artigo em Chinês | MEDLINE | ID: mdl-2736696

RESUMO

A total of 89 cases with extrahepatic jaundice were studied clinically. All patients were divided into two groups at random: control group and Li Dan Ling treatment group. It was found that: (1) liver functions in the patients with obstructive jaundice were injured severely; bilirubin, R15ICG, m-GOT, and gamma-GT were increased significantly; (2) in patients with incomplete biliary obstruction or after the relief of obstruction, liver functions could be improved gradually. They were improved more quickly in patients of the Li Dan Ling treatment group; (3) for the patients suffering from complete biliary tract obstruction, until the obstruction was relieved liver function could not be improved. After the herbal medicine, all the indicators would be further worsened before the relief of the obstruction, and the value of "b" would be positive. The increase in m-GOT and gamma-GT was higher than in the control group, indicating the liver functions were further injured. Therefore, the herbal cholegogue was not suitable for the patients before the obstruction was relieved. The further investigations showed that excretion of bilirubin from the bile could be accelerated by Li Dan Ling, and after herbal administration, the cholesterol level in bile was lowered significantly; the liver blood flow in normal and jaundiced rats would be increased 30 to 90 min. after administering the herbs.


Assuntos
Colestase Extra-Hepática/tratamento farmacológico , Medicamentos de Ervas Chinesas/uso terapêutico , Adulto , Idoso , Bilirrubina/metabolismo , Feminino , Humanos , Fígado/irrigação sanguínea , Testes de Função Hepática , Masculino , Pessoa de Meia-Idade , Fluxo Sanguíneo Regional
10.
Am J Chin Med ; 13(1-4): 127-31, 1985.
Artigo em Inglês | MEDLINE | ID: mdl-4025207

RESUMO

Acupuncture as a therapeutic measure for abdominal pain was early recorded in Huangdi Neijing ("Yellow Emperor's Canon of Medicine"). Fruitful experiences have been accumulated in the practice of the long historical years. Nowadays acupuncture therapy has become one of the main therapeutic methods in surgical acute abdomen and is widely used clinically.


Assuntos
Abdome Agudo/terapia , Terapia por Acupuntura , Terapia por Acupuntura/métodos , Apendicite/terapia , Doenças Biliares/terapia , Colelitíase/terapia , Humanos , Obstrução Intestinal/terapia , Pancreatite/terapia , Úlcera Péptica Perfurada/terapia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA